Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
52.36
+3.60 (7.38%)
At close: Jun 18, 2026, 4:00 PM EDT
51.32
-1.04 (-1.99%)
After-hours: Jun 18, 2026, 6:08 PM EDT
Spruce Biosciences Employees
Spruce Biosciences had 14 employees as of March 31, 2026. The number of employees increased by 6 or 75.00% since the number was last reported on December 31, 2025.
Employees
14
Change
6
Growth
75.00%
Revenue / Employee
n/a
Profits / Employee
-$2,656,500
Market Cap
144.11M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 14 | 6 | 75.00% |
| Dec 31, 2025 | 8 | -13 | -61.90% |
| Dec 31, 2024 | 21 | -8 | -27.59% |
| Dec 31, 2023 | 29 | 2 | 7.41% |
| Dec 31, 2022 | 27 | 12 | 80.00% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| ADC Therapeutics | 193 |
| Molecular Partners AG | 134 |
| Fractyl Health | 100 |
| Alpha Cognition | 71 |
| Corbus Pharmaceuticals Holdings | 36 |
| Enlivex | 34 |
| Genelux | 26 |
| Spero Therapeutics | 25 |
SPRB News
- 3 days ago - Spruce Biosciences initiated with a Buy at Guggenheim - TheFly
- 4 days ago - Spruce Biosciences names Eric Jordan VP, marketing, Tina Gullotta VP, finance - TheFly
- 4 days ago - Spruce Biosciences Appoints Eric Jordan as Vice President, Marketing and Tina Gullotta as Vice President, Finance and Corporate Controller - Business Wire
- 11 days ago - Spruce Biosciences initiated with a Buy at JonesResearch - TheFly
- 11 days ago - Spruce says long-term TA-ERT data presented at MPS Symposium - TheFly
- 11 days ago - Spruce Biosciences Announces Long-Term Tralesinidase Alfa Enzyme Replacement Therapy Data in Sanfilippo Syndrome Type B (MPS IIIB) Presented at the 18th International MPS Symposium - Business Wire
- 15 days ago - Spruce Biosciences Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 18 days ago - Spruce Biosciences price target lowered to $150 from $200 at H.C. Wainwright - TheFly